VACCINOGEN INC

Profile

Company Names

VACCINOGEN INC

Addresses

949 FELL STREET, BALTIMORE, MD 21231

5300 WESTVIEW DRIVE, SUITE 406, FREDERICK, MD 21703

Phone Numbers

410-387-4000
301-668-8400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$18,851,350.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2015-10-27 
$600,000.00 
$3,000,000.00 
$2,400,000.00 
Equity 
7
2015-04-01 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
6
2012-10-23 
$6,642,878.00 
$13,038,003.00 
$6,395,125.00 
Equity 
5
2012-07-18 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2010-09-04 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2010-06-24 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2010-02-05 
$7,600,000.00 
$35,000,000.00 
$27,400,000.00 
Equity 
1
2008-12-03 
$4,008,472.00 
$4,008,472.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
H. 
BARNHILL 
DIRECTOR
VACCINOGEN INC   |  PURE BIOSCIENCE   |  BIZBRAG, INC.
TONY 
 
CAPLIN 
DIRECTOR
VACCINOGEN INC
ALAN 
 
COHEN 
DIRECTOR
INTRACEL HOLDINGS CORP   |  VACCINOGEN INC   |  TRINITY PLACE HOLDINGS INC.   |  ILLUMIO, INC.   |  EVOLV TECHNOLOGIES, INC.   |  CHARTSPAN MEDICAL TECHNOLOGIES, INC.   |  PROPRIO, INC   |  KENTIK TECHNOLOGIES, INC.
HAKAN 
 
EDSTROM 
DIRECTOR
VACCINOGEN INC
DAN 
 
FITZGERALD 
DIRECTOR
VACCINOGEN INC   |  CLEAN CROP TECHNOLOGIES, INC.   |  AIGEN INC.
DANIEL 
 
FITZGERALD 
DIRECTOR
VACCINOGEN INC   |  HEARTBREAK HILL RUNNING COMPANY, INC.   |  CLEAN CROP TECHNOLOGIES, INC.   |  RHIZOCORE TECHNOLOGIES LTD   |  THRIVABLE INC.
MICHAEL 
 
HAGERMAN 
DIRECTOR
INVESTX CAPITAL LTD.   |  INVESTX SPV 16-UNCRN LIMITED PARTNERSHIP   |  VACCINOGEN INC   |  INVESTX SPV 15 - SPTFY LIMITED PARTNERSHIP   |  INVESTX SPV 17 - SPCFY LIMITED PARTNERSHIP   |  INVESTX SPV 14 - LYFT LIMITED PARTNERSHIP   |  INVESTX SPV 25 - SPTFY LIMITED PARTNERSHIP   |  INVESTX SPV 18 - NSTCRT LIMITED PARTNERSHIP   |  INVESTX SPV 20 - UCIVA LIMITED PARTNERSHIP   |  INVESTX SPV 28 - UBER LIMITED PARTNERSHIP   |  INVESTX SPV 45 - SPTFY LIMITED PARTNERSHIP   |  INVESTX SERIES 24 LIMITED PARTNERSHIP   |  INVESTX SPV 23 - DPBX LIMITED PARTNERSHIP   |  INVESTX SERIES 26 LIMITED PARTNERSHIP   |  INVESTX SERIES 27 LIMITED PARTNERSHIP   |  INVESTX SERIES 37 LIMITED PARTNERSHIP   |  INVESTX SERIES 34 LIMITED PARTNERSHIP   |  INVESTX SERIES 18-01 LIMITED PARTNERSHIP   |  INVESTX SERIES 29 LIMITED PARTNERSHIP   |  INVESTX SERIES G-3 LIMITED PARTNERSHIP   |  INVESTX SERIES 18-02 LIMITED PARTNERSHIP   |  INVESTX SERIES 19-01 LIMITED PARTNERSHIP   |  INVESTX SERIES G-4A LIMITED PARTNERSHIP   |  INVESTX SERIES 19-02 LIMITED PARTNERSHIP   |  INVESTX SERIES 29-A LIMITED PARTNERSHIP   |  INVESTX SERIES 19-07 LIMITED PARTNERSHIP   |  INVESTX SERIES 19-08 LIMITED PARTNERSHIP
ANDERS 
 
HALLDIN 
DIRECTOR
VACCINOGEN INC
MICHAEL 
G. 
HANNA, JR. 
DIRECTOR, EXECUTIVE OFFICER
VACCINOGEN INC
DAVID 
 
HATT 
DIRECTOR
VACCINOGEN INC
RONALD 
 
KAISER 
DIRECTOR
VOCUS, INC.   |  VACCINOGEN INC   |  TENABLE NETWORK SECURITY, INC.
DANIEL 
 
KANE 
DIRECTOR
INTRACEL HOLDINGS CORP   |  VACCINOGEN INC   |  IRON MOUNTAIN DATA CENTERS ARIZONA 3, LLC
MICHAEL 
 
KRANDA 
EXECUTIVE OFFICER, DIRECTOR
PTC THERAPEUTICS, INC.   |  VACCINOGEN INC   |  BEAT BIOTHERAPEUTICS CORP   |  TWINSTRAND BIOSCIENCES, INC.
MICHAEL 
L. 
KRANDA 
EXECUTIVE OFFICER, DIRECTOR
ANESIVA, INC.   |  VACCINOGEN INC
JOHN 
 
NICOLIS 
DIRECTOR
VACCINOGEN INC
ANDREW 
L. 
TUSSING 
EXECUTIVE OFFICER, DIRECTOR
VACCINOGEN INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-11-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-10-27 
2015-08-24
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-04-01 
2014-01-24
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-23 
2013-03-22
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-23 
2012-09-04
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-07-18 
2011-06-03
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-02-05 
2010-10-14
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-09-04 
2010-07-02
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-06-24 
2010-03-11
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-02-05 
2010-02-19
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-12-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
VANGUARD CAPITAL
22081
JOHN BLAKE
1014886
VANGUARD CAPITAL
22081
JULI YOUNGBLOOD
1943480